Table 1.
Comparative performance of BRCA1/2 models across cross-validation and non-redundant blind test sets.
| Model | MCC | Sensitivity | Specificity | F1 score | Precision | Accuracy | |
|---|---|---|---|---|---|---|---|
| BRCA1-specific models | |||||||
| BRCA1 | CV | 0.96 | 93% | 98% | 0.96 | 0.96 | 0.96 |
| test | 0.89 | 92% | 82% | 0.86 | 0.87 | 0.86 | |
| BRCA1-combined | CV | 0.96 | 94% | 98% | 0.97 | 0.97 | 0.97 |
| test | 0.89 | 100% | 91% | 0.94 | 0.95 | 0.94 | |
| BRCA1-ENIGMA | CV | 0.96 | 99% | 99% | 0.99 | 0.99 | 0.99 |
| test | 0.82 | 92% | 90% | 0.93 | 0.94 | 0.92 | |
| BRCA2-specific models | |||||||
| BRCA2 | CV | 0.98 | 96% | 98% | 0.98 | 0.98 | 0.98 |
| test | 0.89 | 60% | 100% | 0.92 | 0.93 | 0.92 | |
| BRCA2-combined | CV | 0.89 | 82% | 93% | 0.91 | 0.91 | 0.91 |
| test | 0.83 | 86% | 100% | 0.97 | 0.98 | 0.97 | |
| BRCA2-ENIGMA | CV | 0.95 | 99% | 99% | 0.99 | 0.99 | 0.99 |
| test | 1.00 | 100% | 100% | 1.00 | 1.00 | 1.00 | |
| General model | |||||||
| BRCA1/2 general model | CV | 0.91 | 96% | 98% | 0.96 | 0.96 | 0.96 |
| test | 0.76 | 93% | 100% | 0.93 | 0.93 | 0.92 | |